Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6GYP7

Entry ID Method Resolution Chain Position Source
AF-Q6GYP7-F1 Predicted AlphaFoldDB

62 variants for Q6GYP7

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389238893 44 K>E No EVA
rs3402650027 44 K>N No EVA
rs3389214229 140 Q>R No EVA
rs3389200660 141 D>V No EVA
rs3389236528 167 P>H No EVA
rs3389250736 170 L>* No EVA
rs48588981 179 S>N No EVA
rs3403299407 181 Q>H No EVA
rs3403299434 272 I>T No EVA
rs3403393592 299 I>T No EVA
rs3413058702 320 S>T No EVA
rs3389207910 339 A>T No EVA
rs3389207982 342 S>N No EVA
rs3389172977 354 V>I No EVA
rs48172756 357 V>A No EVA
rs3389238472 359 K>R No EVA
rs3389238165 373 L>I No EVA
rs3389242268 405 R>I No EVA
rs1132232546 461 D>H No EVA
rs1133945773 462 I>R No EVA
rs1133356251 465 S>C No EVA
rs3389253963 484 E>* No EVA
rs3389238881 491 E>G No EVA
rs3389249739 497 S>R No EVA
rs3413113946 525 A>T No EVA
rs3389225875 588 V>I No EVA
rs3389247547 608 S>G No EVA
rs249567531 608 S>N No EVA
rs3389233541 619 L>P No EVA
rs1132240503 717 R>I No EVA
rs1133963496 721 R>L No EVA
rs1133376405 725 G>D No EVA
rs247686918 764 R>H No EVA
rs3389249777 786 H>N No EVA
rs258783345 824 N>S No EVA
rs51655209 825 S>T No EVA
rs3389254025 955 V>M No EVA
rs3389233503 959 T>S No EVA
rs3389225894 1024 H>R No EVA
rs3403304746 1069 G>S No EVA
rs3389214199 1078 M>L No EVA
rs3389247558 1094 W>R No EVA
rs3389212724 1104 L>F No EVA
rs3389225879 1180 L>H No EVA
rs3389233526 1254 H>Q No EVA
rs3389243448 1415 A>S No EVA
rs3389242181 1421 E>K No EVA
rs3389253984 1519 Y>F No EVA
rs3389236580 1561 L>M No EVA
rs3389172992 1592 S>L No EVA
rs265747919 1641 P>L No EVA
rs245514171 1651 A>T No EVA
rs3389238173 1730 E>V No EVA
rs3402648956 1897 L>W No EVA
rs3403472521 1898 R>K No EVA
rs3402648901 1900 L>Q No EVA
rs3389207921 1955 P>E No EVA
rs3389242207 1963 N>K No EVA
rs3389238836 1966 V>I No EVA
rs3389247510 1983 K>T No EVA
rs3403416014 2029 F>L No EVA
rs3389238878 2031 A>V No EVA

No associated diseases with Q6GYP7

1 regional properties for Q6GYP7

Type Name Position InterPro Accession
domain Calcipressin-2, RNA recognition motif 11 - 87 IPR034919

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • Translocated to the nucleus, when associated with TCF3/E12
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

2 GO annotations of molecular function

Name Definition
GTPase activator activity Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP.
protein heterodimerization activity Binding to a nonidentical protein to form a heterodimer.

3 GO annotations of biological process

Name Definition
activation of GTPase activity Any process that initiates the activity of an inactive GTPase through the replacement of GDP by GTP.
regulation of DNA-templated transcription Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
regulation of small GTPase mediated signal transduction Any process that modulates the frequency, rate or extent of small GTPase mediated signal transduction.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5ZMV8 RAP1GAP2 Rap1 GTPase-activating protein 2 Gallus gallus (Chicken) PR
Q684P5 RAP1GAP2 Rap1 GTPase-activating protein 2 Homo sapiens (Human) PR
Q6GYQ0 RALGAPA1 Ral GTPase-activating protein subunit alpha-1 Homo sapiens (Human) PR
P49815 TSC2 Tuberin Homo sapiens (Human) PR
Q5SVL6 Rap1gap2 Rap1 GTPase-activating protein 2 Mus musculus (Mouse) PR
Q61037 Tsc2 Tuberin Mus musculus (Mouse) PR
P86409 RALGAPA1 Ral GTPase-activating protein subunit alpha-1 Sus scrofa (Pig) PR
10 20 30 40 50 60
MFSKKPHGDV KKSTQKVLDT KKDALTRLKH LRIVIENAES IDLKQFFDQH FSHIYYVFFE
70 80 90 100 110 120
NFVTIEASLK QKGHKSQREE LDAILFIFEK ILQLLPERIH QRWQFHSIGL ILKKLLHTGN
130 140 150 160 170 180
SLKIRREGVR LFLLWLQALQ DNCSKEQLWM FSCLIPGFSA PQSEYGPRTL DNLINPPLSL
190 200 210 220 230 240
QETQVTIEEV TPLVPPQSGD KGQEDLTSYF LEALLKYIVI QVKSLEWKNK ENQERGFSFL
250 260 270 280 290 300
FSHFKKFYLP YIFPNICKEN SLYHPVLDIP QIRPKPHYVM IKKDAETNET IYCTKEPFIQ
310 320 330 340 350 360
ARVIVIRWLV SFWLEPKPHS GPNIPGMEGE VLPKNIQRAA ASLVSREESK NDTVDKVDKS
370 380 390 400 410 420
AEPEQSHSNT STLTEREPSS SSLCSIDEEH LTDIEIVRRV FSSKRSNVNF VTEIFRQAFL
430 440 450 460 470 480
LPICEAAAMR KVVKVYQEWI QQEEKPLFMQ EPEDTAITCS DIPCSETVAD HDSAIEDGEK
490 500 510 520 530 540
REEENGTSTS EHVRNSSWTK NGSYQEAFHV CEEATEQNIQ AGTQAVLQVF IINSSNIFLL
550 560 570 580 590 600
EPANEIKNLL DEHTDMCKRI LNIYRYMVVQ VSMDKKTWEQ MLLVLLRVTE SVLKMSSQAF
610 620 630 640 650 660
LQFQGKKSMT LAGRLAGPLF QTLIVAWIKA NLNVYISREL WDDLLSVLSS LTYWEELATE
670 680 690 700 710 720
WSLTMETLTK VLARNLYSLD LSDLPLDKLS EQKQKKHKGK GVGHEFQKVS VDKSFSRGWS
730 740 750 760 770 780
RDQPGQAPMR QRSATTTGSP GTEKARSIVR QKTVDIDDAQ ILPRSTRVRH FSQSEDTGNE
790 800 810 820 830 840
VFGALHEEQP LPRSSSTSDI LEPFTVERAK VNKEDTSPKL PPLNSETGGN SANVPDLMDE
850 860 870 880 890 900
FIAERLRSGN ASTMTRRGSS PGSLEIPKDL PDILNKQNQM RPVDDPGVPS EWTSPASAGS
910 920 930 940 950 960
SDLMSSDSHS DSFSAFQCEG RKFDNFGFGT DIGIPSSADV DLGSGHHQST EEQEVASLTT
970 980 990 1000 1010 1020
LHLDSETSSL NQQAFSAEVA TVTGSESASP VHSALGSRSQ TPSPSTLSRA HIEQKDLQLD
1030 1040 1050 1060 1070 1080
EKLHHSVLQT PDDLEISEFP SECCSVMAGG TLTGWHADVA TVMWRRMLGI LGDVNAIMDP
1090 1100 1110 1120 1130 1140
EIHAQVFDYL CELWQNLAKI RDNLGISADN LTSPSPPVLI PPLRILTPWL FKATMLTDKY
1150 1160 1170 1180 1190 1200
KQGKLHAYKL ICNTMKRRQD VSPNRDFLTH FYNIMHCGLL HIDQDIVNTI IKHCSPQFFS
1210 1220 1230 1240 1250 1260
LGLPGATMLI MDFIIAAGRV ASSAFLNAPR VEAQVLLGSL VCFPNLYCEL PALHPNIPDI
1270 1280 1290 1300 1310 1320
AVSQFTDVKE LIIKTVLSSA RDEPSGPARC VALCSLGIWI CEELVHESHH PQIKEALNVI
1330 1340 1350 1360 1370 1380
CVSLKFTNKT VAHVACNMLH MLVHYVPRLQ IHQPQSPLKI IQILIATITH LLPSTEASSY
1390 1400 1410 1420 1430 1440
EMDKRLVVSL LLCLLDWIMA LPLKTLLQPV HATGAENDKT EKSVLNCIYK VLHGCVYGAQ
1450 1460 1470 1480 1490 1500
SFSNPKYFPI SLSDLASVDY DPFMHLESLK EPEPLHSPDS ERSSKLQPVT EVKTQMQQGL
1510 1520 1530 1540 1550 1560
ISIAARTVIT HLVNHLGHYP MSGGPAMLTS QVCENHDNHY SESTELSPEL FESPNIQFFV
1570 1580 1590 1600 1610 1620
LNNTTLVSCI QIRSEESMPG GGLAAGLVSA NSNVRIIVRD LSGKYSWDSA ILYGPPIVSG
1630 1640 1650 1660 1670 1680
LPEPTSFILS MSDQEKPEEP PTSNECLEDI AVKDGLSLQL RRFRETVPTW STIREEEDVL
1690 1700 1710 1720 1730 1740
DELLQYLGTT SPECLQRTGI SLNVPAPQPL CISEKQENDV INAILKQYTE EKEFVEKHFN
1750 1760 1770 1780 1790 1800
DLNMKASEQD EPTPQKPQSA FYYCRLLLSI LGMNSWDKRR SFHLLKKNEK LLRELRNLDS
1810 1820 1830 1840 1850 1860
RQCRETHKIA VFYVAEGQED KYSILTNIGG SQAYEDFVAG LGWEVNLTNH CGFMGGLQKN
1870 1880 1890 1900 1910 1920
RSTGLTTPYF ATSTVEVIFH VSTRMPSDSD DSLTKKLRHL GNDEVHIVWS EHTRDYRRGI
1930 1940 1950 1960 1970 1980
IPTEFGDVLI VIYPMKNHMF SIQIMKKPEV PFFGPLFDGA IVNGKVLPIM VRSTAINASR
1990 2000 2010 2020 2030
ALKSLIPLYQ NFYEERARYL QTIVQHHLEP TTFEDFAAQV FSPAPYHHFP ADADH